We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Eli Lilly Launches Half-Priced Insulin in Response to Criticism Over Cost
Eli Lilly Launches Half-Priced Insulin in Response to Criticism Over Cost
Eli Lilly’s lower-cost generic of its blockbuster insulin drug Humalog (insulin lispro) hit pharmacies on Wednesday following months of heat from both Congress and the White House over high insulin drug prices.